Jet Li

ImmuneSensor Therapeutics, Inc. is a clinical-stage biotechnology company based in Dallas, TX. ImmuneSensor Therapeutics is building a pipeline of novel small molecule and adc immune stimulating candidates that aim to modulate the innate immune system. The company is led by a team of experienced biotech professionals who are committed to creating novel treatments that harness the body’s innate immune system to treat a wide range of diseases. ImmuneSensor Therapeutics is focused on discovering and developing novel therapies that leverage the incredible versatility and therapeutic potential of the cgas-sting pathway, which is one of the key pathways in the innate immunity system that works to detect both foreign and host-derived DNA. The company was founded in 2014 by Zhijian Chen and Jet Li, and the CEO is Ernest Wong.

ImmuneSensor Therapeutics, Inc. is a clinical-stage biotechnology company based in Dallas, TX. ImmuneSensor Therapeutics is building a pipeline of novel small molecule and adc immune stimulating candidates that aim to modulate the innate immune system. The company is led by a team of experienced biotech professionals who are committed to creating novel treatments that harness the body’s innate immune system to treat a wide range of diseases. ImmuneSensor Therapeutics is focused on discovering and developing novel therapies that leverage the incredible versatility and therapeutic potential of the cgas-sting pathway, which is one of the key pathways in the innate immunity system that works to detect both foreign and host-derived DNA. The company was founded in 2014 by Zhijian Chen and Jet Li, and the CEO is Ernest Wong.